Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis.
about
Determinants for the development of visceral leishmaniasis diseaseDescription of a nanobody-based competitive immunoassay to detect tsetse fly exposureAn insight into the sialome of Glossina morsitans morsitansWhat's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunityBluePort: a platform to study the eosinophilic response of mice to the bite of a vector of Leishmania parasites, Lutzomyia longipalpis sand fliesVaccines to combat the neglected tropical diseases.Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytesImmunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease.Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin AmericaSerological responses and biomarker evaluation in mice and pigs exposed to tsetse fly bites.Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E₂ production in murine macrophages.Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis.Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence?Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen.Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis.Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by Phlebotomus papatasi.Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans.Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasisComparative analysis of salivary gland transcriptomes of Phlebotomus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis.Meta-analysis of the effects of insect vector saliva on host immune responses and infection of vector-transmitted pathogens: a focus on leishmaniasis.Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in TunisiaNew Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in LeishmaniasisKinetics of Anti-Phlebotomus perniciosus Saliva Antibodies in Experimentally Bitten Mice and Rabbits.The immune response to sand fly salivary proteins and its influence on leishmania immunityRecombinant Salivary Proteins of Phlebotomus orientalis are Suitable Antigens to Measure Exposure of Domestic Animals to Sand Fly Bites.Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.Biomarkers for exposure to sand flies bites as tools to aid control of leishmaniasis.Delayed-type hypersensitivity to sand fly saliva in humans from a leishmaniasis-endemic area of Mali is Th1-mediated and persists to midlife.Sand flies, Leishmania, and transcriptome-borne solutionsSand-fly saliva-leishmania-man: the trigger trioLeishmania vaccine development: exploiting the host-vector-parasite interface.Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and LeishmaniaA sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control.Antibody response to sand fly saliva is a marker of transmission intensity but not disease progression in dogs naturally infected with Leishmania infantum.Lutzomyia longipalpis Saliva Drives Interleukin-17-Induced Neutrophil Recruitment Favoring Leishmania infantum Infection.
P2860
Q27027871-7BADB826-2220-4796-AAF8-6B9F7645DB52Q27304633-D485F606-D5CB-4502-B931-C98AF3978213Q27491348-1EE4A109-58A3-410E-822A-A4DF7D134FC3Q28607896-F7745F12-4268-4EB9-89CF-5ADAF18CEAC3Q28748688-A5855481-53D9-4852-AAB4-1610015AE0B1Q30425005-6EE49F7F-58F3-48D6-B29B-99CFDE1352A3Q31032971-57E0379F-AAD7-45D4-9315-537AC25AD824Q33328462-461387B3-B7AD-4D7E-A9A6-028AD845A9B2Q33450546-BB4ECDF9-0CD2-48DD-903B-E5924FBC6823Q33547356-3E8EBC00-B0A1-4CCE-A665-5D813F86EF2FQ33547359-23BAE636-B174-47E0-91F0-1BB374DCE780Q33650544-3004F086-2A36-4B75-9348-B08739224785Q33745236-426E8A6B-00DC-4AE6-AA19-B16AED65F048Q33784499-4F825DB1-86FF-4158-B568-2F907D1DC841Q34019064-4D673AED-A715-4540-9E4B-D63E222627EDQ34160109-03708793-D3B8-4C08-BB10-128E163B64F5Q34282246-1B7C1642-5B22-4C00-A53B-491BCB92EE4EQ34339785-25A29018-BAC7-485B-91A2-0123CF28CE8BQ34500853-315F4185-F898-43CB-B526-96DB17C298FFQ34875390-66D1EB4C-12BA-41BD-A983-05C2FC3B41A3Q35109201-8A1BAEAC-05A0-400F-B542-984CCA4D8D4DQ35294714-E358F0CA-66BD-4081-A14E-6C8EDDC80324Q35774617-CAA804A7-94A0-4514-8A88-0E7CEB3EC3EFQ35838090-966847FF-BB23-4E60-BDF3-229DA5E4991FQ35841520-341ECC3C-DD27-45C3-8E54-399B6B6E3B9CQ35952185-FBF524F2-A148-45D2-9964-9AE445C0B764Q35960973-82ED5FD9-FB0B-4A71-B5FF-1ACFD095792CQ35965262-7E2D34A1-704B-4BFC-9279-F15123B75C14Q35974756-18043FA4-FB1A-4F32-9D56-6E5BED289D0CQ36488101-5B708F8C-1E4C-45C6-B1BE-655A32878B93Q37162773-38830D74-0D82-40E2-BF2A-90DF0C60EC71Q37321931-EF7B1C9E-34B1-4E81-B09C-4C25672F3562Q38643410-627B7217-CCC8-4D5A-9656-6CBD497ACA62Q38680919-4DDF9D24-415E-42BC-9675-337A37B45DC4Q41186389-D69A3C1C-9EB1-450C-894B-B8058ED821FAQ45412433-472F448C-6462-4082-B76E-8C9E2D1938BBQ45980979-0526F931-D070-4E83-8EE0-72DA769F3D51Q48307725-79B76743-473B-4A0B-9773-020372B082DCQ55289972-2FCA7480-2DBF-479B-8D81-C0E9D128B733
P2860
Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@en
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@nl
type
label
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@en
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@nl
prefLabel
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@en
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis.
@nl
P2093
P2860
P50
P356
P1476
Human anti-saliva immune respo ...... vector, Lutzomyia longipalpis
@en
P2093
André Báfica
Andréa Bomura
Bruno B Andrade
Fábio Paes
José C Miranda
Vera Vinhas
P2860
P304
P356
10.1002/EJI.200737431
P407
P577
2007-11-01T00:00:00Z